Precision Virologics
Saint Louis · Founded 2016
About Precision Virologics
Precision’s technology will provide the next-generation vaccines for emerging infectious diseases. PV-ZIKV, our vaccine candidate for Zika, has significant advantages over competitors, including the lack of cross-reactivity among flaviviruses and increased potency
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Grant (Mar 2019)
- Website: http://precisionvx.com/
- Phone: [email protected]
Industries & Categories
Biotechnology, Commercial, Health Care, Medical Device
Canonical: https://fsome.com/organization/precision-virologics-31284 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.